Extendicare Historical Cash Flow
| EXE Stock | CAD 10.62 0.04 0.38% |
Analysis of Extendicare cash flow over time is an excellent tool to project Extendicare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 45.8 M or Capital Expenditures of 135.9 M as it is a great indicator of Extendicare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Extendicare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Extendicare is a good buy for the upcoming year.
Extendicare |
About Extendicare Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Extendicare balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Extendicare's non-liquid assets can be easily converted into cash.
Extendicare Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Most accounts from Extendicare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Extendicare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Extendicare's Change To Operating Activities is very stable compared to the past year. As of the 30th of November 2024, Other Cashflows From Investing Activities is likely to grow to about 310.7 M, while Sale Purchase Of Stock is likely to drop (11.6 M).
Extendicare cash flow statement Correlations
Click cells to compare fundamentals
Extendicare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Extendicare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 28.6M | 85.5M | (75.3M) | 62.7M | (92.1M) | (87.5M) | |
| Free Cash Flow | 12.0M | 88.2M | (6.1M) | (2.9M) | (106.1M) | (100.8M) | |
| Change In Working Capital | (4.8M) | 22.1M | 13.6M | 54.1M | (41.2M) | (39.1M) | |
| Begin Period Cash Flow | 65.9M | 94.5M | 180.0M | 104.6M | 167.3M | 97.9M | |
| Other Cashflows From Financing Activities | (1.8M) | (3.9M) | (1.9M) | (56K) | 1.9M | 2.0M | |
| Depreciation | 39.6M | 38.8M | 38.6M | 32.1M | 32.6M | 45.8M | |
| Other Non Cash Items | (27.0M) | (12.3M) | (10.5M) | (59.6M) | (10.3M) | (9.8M) | |
| Capital Expenditures | 33.2M | 33.1M | 69.5M | 101.6M | 129.4M | 135.9M | |
| Total Cash From Operating Activities | 45.2M | 121.3M | 63.4M | 98.7M | 23.3M | 22.1M | |
| Net Income | 28.6M | 54.2M | 11.5M | 69.6M | 34.0M | 31.8M | |
| Total Cash From Financing Activities | (28.7M) | (38.2M) | (74.8M) | (191.9M) | (30.9M) | (32.5M) | |
| End Period Cash Flow | 94.5M | 180.0M | 104.6M | 167.3M | 75.2M | 99.6M | |
| Dividends Paid | 37.2M | 41.3M | 43.0M | 42.6M | 40.4M | 35.9M | |
| Change To Account Receivables | 200K | (7.9M) | (13.8M) | 4.0M | (29.2M) | (27.7M) | |
| Stock Based Compensation | 1.6M | 2.0M | 3.6M | 2.6M | 4.2M | 4.4M | |
| Net Borrowings | 10.3M | 7.0M | (30.0M) | (114.2M) | (102.8M) | (97.7M) | |
| Total Cashflows From Investing Activities | 12.8M | 2.0M | (63.7M) | 155.6M | 179.0M | 187.9M | |
| Change To Operating Activities | 1.1M | (19.9M) | 12.0M | 1.4M | 1.3M | 2.1M | |
| Other Cashflows From Investing Activities | 46.0M | 35.1M | 5.8M | 257.3M | 295.9M | 310.7M | |
| Change To Netincome | (19.3M) | 6.2M | (283K) | (57.0M) | (51.3M) | (48.8M) | |
| Change To Liabilities | (5.1M) | 49.9M | 15.4M | 48.6M | 55.9M | 58.7M | |
| Investments | 12.8M | 2.0M | (63.7M) | 155.6M | (84.5M) | (80.2M) |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
The Cash Flow Statement is a financial statement that shows how changes in Extendicare balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Extendicare's non-liquid assets can be easily converted into cash.